Ownership history in GEODE CAPITAL MANAGEMENT, LLC Β· 19 quarters on record
This page tracks every 13F SEC filing in which GEODE CAPITAL MANAGEMENT, LLC reported a position in LEXARIA BIOSCIENCE CORP (LEXX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π GEODE CAPITAL MANAGEMENT, LLC underperformed the S&P 500 by β5.9% annually on this LEXX position. Timing score: 31% (4/13 decisions correct). Average cost basis: $3.38. Maximum drawdown during holding period: β91.1%.
β Significantly underperformed the S&P 500 by 5.9% ann.
11 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
4 of 13 add/trim decisions correct
Best entry: $0.62 (2025 Q4) Β· Worst: $7.00 (2021 Q2)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
10 adds Β· 4 trims. Bought during 6 of 11 down-price quarters. π Consistently bullish β fund kept accumulating this position.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size